Literature DB >> 19801831

Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats.

Yasushi Ikarashi1, Seiichi Iizuka, Sachiko Imamura, Takuji Yamaguchi, Kyoji Sekiguchi, Hitomi Kanno, Zenji Kawakami, Mitsutoshi Yuzurihara, Yoshio Kase, Shuichi Takeda.   

Abstract

Effects of yokukansan (TJ-54) on memory disturbance and behavioral and psychological symptoms of dementia (BPSD) were investigated in thiamine-deficient (TD) rats which were produced by feeding a TD diet for 37 d. Daily oral administration of TJ-54 (0.5, 1.0 g/kg) ameliorated the memory disturbance, anxiety-like behavior, the increase in aggressive behaviors, the decrease in social behaviors, and several neurological symptoms including opisthotonus observed in TD rats, in a dose-dependent manner. In addition, histopathological examinations showed that TJ-54 inhibited the degeneration of neuronal and astroglial cells in the brain stem, hippocampus and cortex in TD rats. Microdialysis experiments showed that TJ-54 inhibited extracellular glutamate rise in the ventral posterior medial thalamus in TD rats. These results suggest that TJ-54 possesses the preventive or progress inhibitive effect against the development of memory disturbance and BPSD-like behaviors induced by the degeneration of neuronal and astroglial cells resulting from TD. TJ-54 may inhibit glutamate-mediated excitotoxicity as one of mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801831     DOI: 10.1248/bpb.32.1701

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  27 in total

1.  Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).

Authors:  Tsuyoshi Miyaoka; Motohide Furuya; Jun Horiguchi; Rei Wake; Sadayuki Hashioka; Masaya Tohyama; Norio Mori; Yoshio Minabe; Masaomi Iyo; Shyuichi Ueno; Sachiko Ezoe; Kenta Murotani; Syuzo Hoshino; Haruo Seno
Journal:  Psychopharmacology (Berl)       Date:  2014-06-13       Impact factor: 4.530

2.  Effects of yokukansan on anxiety-like behavior in a rat model of cerebrovascular dementia.

Authors:  Ai Nogami; Yuri Sakata; Naoki Uchida; Kazuko Yamaguchi; Chihiro Kawasaki; Taro Shindo; Kaori Kubota; Shutaro Katsurabayashi; Kotaro Takasaki; Kenichi Mishima; Ryoji Nishimura; Michihiro Fujiwara; Katsunori Iwasaki
Journal:  J Nat Med       Date:  2010-12-09       Impact factor: 2.343

3.  Isoliquiritigenin is a novel NMDA receptor antagonist in kampo medicine yokukansan.

Authors:  Zenji Kawakami; Yasushi Ikarashi; Yoshio Kase
Journal:  Cell Mol Neurobiol       Date:  2011-06-21       Impact factor: 5.046

4.  The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan.

Authors:  Masahiro Tabuchi; Sachiko Imamura; Zenji Kawakami; Yasushi Ikarashi; Yoshio Kase
Journal:  Cell Mol Neurobiol       Date:  2012-04-10       Impact factor: 5.046

5.  Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response.

Authors:  Toru Hiratsuka; Shinsuke Matsuzaki; Shingo Miyata; Mitsuhiro Kinoshita; Kazuaki Kakehi; Shinji Nishida; Taiichi Katayama; Masaya Tohyama
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

6.  Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice.

Authors:  Naoko Funakushi; Takuji Yamaguchi; Ju Jiang; Sachiko Imamura; Takatoshi Kuhara; Hajime Suto; Rie Ueki; Yoshio Kase; Hiroyuki Kobayashi; Hideoki Ogawa; Shigaku Ikeda
Journal:  Arch Dermatol Res       Date:  2011-03-02       Impact factor: 3.017

7.  Antiallodynic effect of herbal medicine yokukansan on peripheral neuropathy in rats with chronic constriction injury.

Authors:  Yasuyuki Suzuki; Hiromasa Mitsuhata; Mitsutoshi Yuzurihara; Yoshio Kase
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-08       Impact factor: 2.629

8.  The effect of Coriandrum sativum seed extract on the learning of newborn mice by electric shock: interaction with caffeine and diazepam.

Authors:  Seyed Sadegh Zargar-Nattaj; Pooya Tayyebi; Vahid Zangoori; Yasaman Moghadamnia; Hasan Roodgari; Seyed Gholamali Jorsaraei; Ali Akbar Moghadamnia
Journal:  Psychol Res Behav Manag       Date:  2011-01-21

9.  Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial.

Authors:  Tsuyoshi Miyaoka; Motohide Furuya; Jun Horiguchi; Rei Wake; Sadayuki Hashioka; Masaya Thoyama; Kenta Murotani; Norio Mori; Yoshio Minabe; Masaomi Iyo; Shuichi Ueno; Sachiko Ezoe; Syuzo Hoshino; Haruo Seno
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-14       Impact factor: 2.629

10.  Yokukansan improves distress of medical staff, and cognitive function and motivation in patients with destructive and aggressive behaviors after traumatic brain injury.

Authors:  Tomomichi Kan'o; Jing-Yan Han; Kuniaki Nakahara; Shingo Konno; Mayuko Shibata; Takao Kitahara; Kazui Soma
Journal:  Acute Med Surg       Date:  2014-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.